Financial Calendar
Interim report Q1, 2019
Annual General Meeting 2019
Interim report Q2, 2019
Interim report Q3, 2019
Contact Investor Relations
Martin Åmark, CEO/IR
+46 (0) 763 09 37 77
martin.amark@xbrane.com
Company
Presentation
Financial Hearings
Börsveckan
Stockholm, Sweden
February 19, 2019
Presenter:
Martin Åmark, CEO Xbrane Biopharma